Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy
Crossref DOI link: https://doi.org/10.1007/s12185-015-1766-4
Published Online: 2015-03-04
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Amaki, Jun
Onizuka, Makoto
Ohmachi, Ken
Aoyama, Yasuyuki
Hara, Ryujiro
Ichiki, Akifumi
Kawai, Hidetsugu
Sato, Ai
Miyamoto, Mitsuki
Toyosaki, Masako
Machida, Shinichiro
Kojima, Minoru
Shirasugi, Yukari
Kawada, Hiroshi
Ogawa, Yoshiaki
Ando, Kiyoshi
Text and Data Mining valid from 2015-03-04